Related Experiment Video
Updated: May 11, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Vascular calcification
Ziad A Massy1, Tilman B Drüeke
1Unité 1088 de l'Inserm, UFR de Médecine et de Pharmacie, Université de Picardie Jules Verne, Amiens, France. ziad.massy@apr.aphp.fr
Purpose Of Review:
This review presents new evidence related to molecular mechanisms involved in the process of cardiovascular calcification, as well as to discuss new biomarkers and novel therapeutic strategies related to vascular calcification in chronic kidney disease (CKD) patients.
Recent Findings:
microRNAs have emerged as potential players in the genesis of osteo-chondrogenic transformation, depending on the stimulus and the localization of vascular calcification. The disturbances of the fibroblast growth factor-23 (FGF23)/alpha-Klotho (Klotho) axis observed in CKD appear to play an important role in CKD-associated vascular calcification. Numerous studies have identified circulating biomarkers potentially responsible for vascular calcification and have evaluated their link with this process. The respective role of these biomarkers is not yet elucidated. Beyond phosphate binders, modulation of calcium-sensing receptor and vitamin K supplementation come into sight as new potential strategies to prevent cardiovascular calcification.
Conclusion:
A better understanding of the molecular mechanisms which are responsible for cardiovascular calcification have led to a better detection and more adequate follow-up of this pathologic process, as well as the identification of novel therapeutic targets. Whether these new insights will lead to improved care and better survival of CKD patients with cardiovascular calcification remains to be demonstrated.
Insights
New evidence reveals microRNAs and the FGF23/alpha-Klotho axis are key in cardiovascular calcification in chronic kidney disease (CKD). Novel biomarkers and therapies like vitamin K supplementation show promise for CKD patients.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Molecular Biology
Background:
- Cardiovascular calcification is a significant concern in chronic kidney disease (CKD).
- Understanding the molecular underpinnings is crucial for effective management.
Purpose of the Study:
- To review new evidence on molecular mechanisms of cardiovascular calcification.
- To discuss emerging biomarkers and therapeutic strategies for vascular calcification in CKD patients.
Main Methods:
- Literature review of recent studies on cardiovascular calcification.
- Analysis of molecular pathways, biomarkers, and therapeutic interventions.
Main Results:
- MicroRNAs are implicated in osteo-chondrogenic transformation in vascular calcification.
- Disturbances in the FGF23/alpha-Klotho axis are important in CKD-associated calcification.
- Numerous circulating biomarkers for vascular calcification have been identified, but their roles require further elucidation.
- Potential therapeutic strategies include modulating the calcium-sensing receptor and vitamin K supplementation.
Conclusions:
- Improved understanding of molecular mechanisms aids detection and follow-up of cardiovascular calcification.
- Novel therapeutic targets have been identified.
- The clinical impact of these advancements on CKD patient outcomes requires further investigation.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Skeleton and Calcium Homeostasis
Atherosclerosis I: Introduction
The Bone Matrix
Coronary Artery Disease II: Pathophysiology
Venous Thrombosis I: Introduction

